MorphoSys AG (Morphosys) develops monoclonal antibodies for therapeutic, diagnostic and research applications. It offers therapeutic drugs for various diseases including cancer, rheumatoid arthritis and Alzheimer's disease. The company's patented antibody library technologies including HuCAL are used in research and diagnostics applications. Its product pipeline includes drugs in various stages of development for the treatment of different types of cancer, psoriasis, rheumatoid arthritis, COPD, asthma and other inflammatory diseases. Its cancer drug candidates include MOR208 (Phase II), MOR202 (Phase II), MOR209/ES414 (Phase I) tarextumab (Phase II and Phase I) and NOV-10 (Phase I), among others. The company’s inflammatory drug candidates comprise MOR103 (Phase II), guselkumab (Phase III and Phase II) and NOV-8 (Phase I), among others. It has research and development agreements with pharmaceutical and biotechnology companies such as Boehringer Ingelheim, GlaxoSmithKline, and Pfizer among others. Morphosys is headquartered in Planegg, Munich, Germany.
MorphoSys AG Key Recent Developments
Sep 08, 2015: MorphoSys Provides an Update on its Proprietary Development Portfolio Jul 30, 2015: MorphoSys's Partner Heptares Initiates Proprietary Therapeutic Antibody Program against a GPCR Target Jul 27, 2015: MorphoSys Reports Results for the First Six Months of 2015 May 08, 2015: Annual General Meeting of MorphoSys AG Elects New Supervisory Board Members May 04, 2015: MorphoSys Reports Results for the First Three Months of 2015
This comprehensive SWOT profile of MorphoSys AG provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table Of Contents
MorphoSys AG (MOR) - Financial and Strategic SWOT Analysis Review Table of Contents
Section 1 - About the Company
MorphoSys AG - Key Information MorphoSys AG - Overview MorphoSys AG - Key Employees MorphoSys AG - Key Employee Biographies MorphoSys AG - Key Operational Heads MorphoSys AG - Major Products and Services MorphoSys AG - History MorphoSys AG - Company Statement MorphoSys AG - Locations And Subsidiaries MorphoSys AG - Key Manufacturing facilities Head Office Other Locations and Subsidiaries
Section 2 - Company Analysis
MorphoSys AG - Business Description MorphoSys AG - Corporate Strategy MorphoSys AG - SWOT Analysis SWOT Analysis - Overview MorphoSys AG - Strengths MorphoSys AG - Weaknesses MorphoSys AG - Opportunities MorphoSys AG - Threats MorphoSys AG - Key Competitors
Section 3 - Company Financial Performance Charts
MorphoSys AG - Financial Ratios Financial Ratios - Capital Market Ratios Financial Ratios - Annual Ratios Financial Ratios - Interim Ratios Financial Ratios - Ratio Charts
Section 4 - Appendix
Appendix Methodology Ratio Definitions About GlobalData Contact Us Disclaimer
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
MorphoSys AG, Key Information MorphoSys AG, Key Ratios MorphoSys AG, Share Data MorphoSys AG, Major Products and Services MorphoSys AG, History MorphoSys AG, Key Employees MorphoSys AG, Key Employee Biographies MorphoSys AG, Key Operational Heads MorphoSys AG, Other Locations MorphoSys AG, Subsidiaries MorphoSys AG, Key Manufacturing facilities MorphoSys AG, Key Competitors MorphoSys AG, SWOT Analysis MorphoSys AG, Ratios based on current share price MorphoSys AG, Annual Ratios MorphoSys AG, Interim Ratios Currency Codes Capital Market Ratios Equity Ratios Profitability Ratios Cost Ratios Liquidity Ratios Leverage Ratios Efficiency Ratios
List of Figures
MorphoSys AG, Performance Chart MorphoSys AG, Ratio Charts